BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 2015; 21(6): 1956-1971 [PMID: 25684965 DOI: 10.3748/wjg.v21.i6.1956]
URL: https://www.wjgnet.com/1948-5182/full/v21/i6/1956.htm
Number Citing Articles
1
Johan Vessby, Maria Lampinen, Mikael Åberg, Fredrik Rorsman, Agneta Siegbahn, Alkwin Wanders, Marie Carlson. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitisUpsala Journal of Medical Sciences 2019; 124(4): 238 doi: 10.1080/03009734.2019.1689209
2
David Ellinghaus, Luke Jostins, Sarah L Spain, Adrian Cortes, Jörn Bethune, Buhm Han, Yu Rang Park, Soumya Raychaudhuri, Jennie G Pouget, Matthias Hübenthal, Trine Folseraas, Yunpeng Wang, Tonu Esko, Andres Metspalu, Harm-Jan Westra, Lude Franke, Tune H Pers, Rinse K Weersma, Valerie Collij, Mauro D'Amato, Jonas Halfvarson, Anders Boeck Jensen, Wolfgang Lieb, Franziska Degenhardt, Andreas J Forstner, Andrea Hofmann, Stefan Schreiber, Ulrich Mrowietz, Brian D Juran, Konstantinos N Lazaridis, Søren Brunak, Anders M Dale, Richard C Trembath, Stephan Weidinger, Michael Weichenthal, Eva Ellinghaus, James T Elder, Jonathan N W N Barker, Ole A Andreassen, Dermot P McGovern, Tom H Karlsen, Jeffrey C Barrett, Miles Parkes, Matthew A Brown, Andre Franke. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared lociNature Genetics 2016; 48(5): 510 doi: 10.1038/ng.3528
3
Franziska Mathies, Niklas Steffens, Doerte Kleinschmidt, Friederike Stuhlmann, Francis J Huber, Urmi Roy, Thomas Meyer, Marc Luetgehetmann, Mareike von Petersdorff, Oliver Seiz, Johannes Herkel, Christoph Schramm, Richard A Flavell, Nicola Gagliani, Christian Krebs, Ulf Panzer, Zeinab Abdullah, Till Strowig, Tanja Bedke, Samuel Huber. Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T CellsThe Journal of Immunology 2018; 201(12): 3558 doi: 10.4049/jimmunol.1800711
4
Ming-Hsi Wang, Omar Y Mousa, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly C Cushing, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceInflammatory Bowel Diseases 2020; 26(5): 774 doi: 10.1093/ibd/izz209
5
Christopher Chang, Atsushi Tanaka, Christopher Bowlus, M. Eric Gershwin. The use of biologics in the treatment of autoimmune liver diseaseExpert Opinion on Investigational Drugs 2020; 29(4): 385 doi: 10.1080/13543784.2020.1733527
6
Christian Schineis. Chirurgie des unteren Gastrointestinaltrakts und Allgemeine ChirurgieSpringer Reference Medizin 2024; : 235 doi: 10.1007/978-3-662-63356-4_72
7
Shintaro Akiyama, Soma Fukuda, Joshua M Steinberg, Hideo Suzuki, Kiichiro Tsuchiya. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseasesWorld Journal of Gastroenterology 2022; 28(25): 2843-2853 doi: 10.3748/wjg.v28.i25.2843
8
Kwang Woo Kim, Hyoun Woo Kang. Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel diseaseIntestinal Research 2023; 21(4): 413 doi: 10.5217/ir.2023.00133
9
Alicia R. Andrews, Juan Putra. Special Considerations in Pediatric Inflammatory Bowel Disease PathologyDiagnostics 2025; 15(7): 831 doi: 10.3390/diagnostics15070831
10
Elisa Catanzaro, Enrico Gringeri, Nora Cazzagon, Annarosa Floreani, Umberto Cillo, Patrizia Burra, Martina Gambato. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center DataJournal of Personalized Medicine 2024; 14(3): 222 doi: 10.3390/jpm14030222
11
David Huynh, Denis Rubtsov, Myat Myat Khaing. Efficacy of Biologics in the Treatment of Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisCureus 2024;  doi: 10.7759/cureus.56182
12
Ayesha Shah, Graeme A. Macdonald, Mark Morrison, Gerald Holtmann. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional FrameworkAmerican Journal of Gastroenterology 2020; 115(6): 814 doi: 10.14309/ajg.0000000000000604
13
Christopher Bowlus, David N. Assis, David Goldberg. Zakim and Boyer's Hepatology2018; : 626 doi: 10.1016/B978-0-323-37591-7.00043-4
14
Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Massoud Vosough. PSC associated inflammatory bowel disease: a distinct entityExpert Review of Gastroenterology & Hepatology 2022; 16(2): 129 doi: 10.1080/17474124.2022.2031979
15
Michael F. McGee, Scott A. Strong. Inflammatory, infectious, and ischemic disorders of the pelvic pouchSeminars in Colon and Rectal Surgery 2019; 30(1): 10 doi: 10.1053/j.scrs.2019.01.004
16
Tej I. Mehta, Simcha Weissman, Brian M. Fung, John Sotiriadis, Keith D. Lindor, James H. Tabibian. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta‐analysisLiver International 2021; 41(10): 2418 doi: 10.1111/liv.15007
17
Pooya Jalali, Malihe Rezaee, Alireza Yaghoobi, Moein Piroozkhah, Mohammad Reza Zabihi, Shahram Aliyari, Zahra Salehi. Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitisGenomics & Informatics 2025; 23(1) doi: 10.1186/s44342-025-00045-4
18
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitisJournal of Hepatology 2022; 77(3): 761 doi: 10.1016/j.jhep.2022.05.011
19
Kate D. Williamson, Roger W. Chapman. Primary sclerosing cholangitis: a clinical updateBritish Medical Bulletin 2015; 114(1): 53 doi: 10.1093/bmb/ldv019
20
Magali Svrcek, Paula Borralho Nunes, Vincenzo Villanacci, Laurent Beaugerie, Gerhard Rogler, Gert De Hertogh, Monika Tripathi, Roger Feakins. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of InflammationJournal of Crohn's and Colitis 2018;  doi: 10.1093/ecco-jcc/jjy132
21
Christian Schineis. Viszeral- und AllgemeinchirurgieSpringer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-61724-3_72-1
22
Kimberly Ortiz, Zeliha Cetin, Yiyue Sun, Zhiping Hu, Takeshi Kurihara, Edgar N. Tafaleng, Rodrigo M. Florentino, Alina Ostrowska, Alejandro Soto-Gutierrez, Lanuza A.P. Faccioli. Human Hepatocellular response in Cholestatic Liver DiseasesOrganogenesis 2023; 19(1) doi: 10.1080/15476278.2023.2247576
23
Amera Elzubeir, Juliet High, Matthew Hammond, Lee Shepstone, Martin Pond, Martine Walmsley, Palak Trivedi, Emma Culver, Guruprasad Aithal, Jessica Dyson, Douglas Thorburn, Leo Alexandre, Simon Rushbrook. Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot studyBMJ Open Gastroenterology 2025; 12(1): e001596 doi: 10.1136/bmjgast-2024-001596
24
Fangming Wang, Junhui Xiao. The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomizationScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-83085-0
25
Mike Van Der Have, Bas Oldenburg. Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition?Inflammatory Bowel Diseases 2020; 26(5): 780 doi: 10.1093/ibd/izz211
26
Brigid Pinnuck, Kate D. Lynch. Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitisExpert Opinion on Pharmacotherapy 2024; 25(13): 1835 doi: 10.1080/14656566.2024.2407022
27
Olga V. Usoltseva, Andrey N. Surkov, Alexander S. Potapov, Goar B. Movsisyan, Vladislav V. Chernikov. Association of autoimmune hepatobiliary pathology with inflammatory bowel diseases in childrenRussian Pediatric Journal 2022; 25(2): 106 doi: 10.46563/1560-9561-2022-25-2-106-115
28
Zhen-Jiao Li, Hong-Zhong Gou, Yu-Lin Zhang, Xiao-Jing Song, Lei Zhang. Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic valueWorld Journal of Gastroenterology 2022; 28(44): 6213-6229 doi: 10.3748/wjg.v28.i44.6213
29
Tanja Bedke, Friederike Stumme, Miriam Tomczak, Babett Steglich, Rongrong Jia, Simon Bohmann, Agnes Wittek, Jan Kempski, Emilia Göke, Marius Böttcher, Dominik Reher, Anissa Franke, Maximilian Lennartz, Till Clauditz, Guido Sauter, Thorben Fründt, Sören Weidemann, Gisa Tiegs, Christoph Schramm, Nicola Gagliani, Penelope Pelczar, Samuel Huber. Protective function of sclerosing cholangitis on IBDGut 2024; 73(8): 1292 doi: 10.1136/gutjnl-2023-330856
30
Eike Matthias Wacker, Florian Uellendahl-Werth, Saptarshi Bej, Olaf Wolkenhauer, Mette Vesterhus, Wolfgang Lieb, Andre Franke, Tom Hemming Karlsen, Trine Folseraas, David Ellinghaus. Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitisJHEP Reports 2024; 6(2): 100988 doi: 10.1016/j.jhepr.2023.100988
31
Mahmoud Mahfouz, Paul Martin, Andres F. Carrion. Hepatic Complications of Inflammatory Bowel DiseaseClinics in Liver Disease 2019; 23(2): 191 doi: 10.1016/j.cld.2018.12.003
32
Richard Kellermayer. Should all pediatric patients with type 1 autoimmune hepatitis be screened for inflammatory bowel disease?JHEP Reports 2025; 7(3): 101291 doi: 10.1016/j.jhepr.2024.101291
33
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver TransplantationTransplantology 2021; 2(2): 162 doi: 10.3390/transplantology2020016
34
Ming-Hsi Wang, Jessica J. Friton, Nancy Rebert, Kelly Monroe, Billy D. Nix, Claudio Fiocchi, Laura E. Raffals, Jonathan A. Leighton, Shabana F. Pasha, Michael F. Picco, Rodney D. Newberry, Jean-Paul Achkar, William A. Faubion. Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative ColitisClinical and Translational Gastroenterology 2023; 14(9): e00615 doi: 10.14309/ctg.0000000000000615
35
Elisa Catanzaro, Enrico Gringeri, Patrizia Burra, Martina Gambato. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance StrategiesCancers 2023; 15(20): 4947 doi: 10.3390/cancers15204947
36
In Sub Han, Dong Hoon Baek, Seung Min Hong, Bong Eun Lee, Moon Won Lee, Gwang Ha Kim, Geun Am Song. Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitisInternational Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04464-z
37
Remi Mahmoud, Shailja C. Shah, Joren R. ten Hove, Joana Torres, Erik Mooiweer, Daniel Castaneda, Jason Glass, Jordan Elman, Akash Kumar, Jordan Axelrad, Thomas Ullman, Jean-Frederic Colombel, Bas Oldenburg, Steven H. Itzkowitz. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel DiseasesGastroenterology 2019; 156(5): 1333 doi: 10.1053/j.gastro.2018.11.067
38
Petronela Nicoleta Seritean Isac, Diana Popescu, Tudor Marcel Genes, Minerva Codruta Badescu, Ioana Irina Rezus, Nicoleta Dima, Ana Roxana Rusu Ganceanu, Elena Rezus, Ciprian Rezus. Etiopathogenic and Clinical Aspects in Inflammatory Bowel Disease – Literature ReviewJournal of Interdisciplinary Medicine 2021; 6(3): 132 doi: 10.2478/jim-2021-0031
39
Burak Demir, Elgin Özkan, Seda Kaynak Şahap, Gizem Sütçü, Ceyda Tuna Kırsaçlıoğlu, Çiğdem Soydal, Ömer Suat Fitoz, Aydan Kansu Tanca, Emel Ünal. A Rare Case of “Periportal Cuffing” as an Incidental Finding on <sup>18</sup>F-FDG PET/CTMolecular Imaging and Radionuclide Therapy 2023; 32(3): 252 doi: 10.4274/mirt.galenos.2023.53254
40
Ruben J. Colman, Jasbir Dhaliwal, Michael J. Rosen. Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision MedicineFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.634739
41
Bettina M Buchholz, Panagis M Lykoudis, Reena Ravikumar, Joerg M Pollok, Giuseppe K Fusai. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipientsWorld Journal of Gastroenterology 2018; 24(28): 3171-3180 doi: 10.3748/wjg.v24.i28.3171
42
Brian M Fung, Keith D Lindor, James H Tabibian. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategiesWorld Journal of Gastroenterology 2019; 25(6): 659-671 doi: 10.3748/wjg.v25.i6.659
43
Mohammad Egbaria, Amir Bieber, Abed Mahamid, Rawi Hazzan. Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosisBMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03852-9
44
Dongyuan Zheng, Qinke Xu, Jin Wu, Zhouyue Gu, Jieya Chen, Yingchao Liu. Prevalence and bidirectional association between primary sclerosing cholangitis and Crohn's disease: A systematic review and meta-analysisGastroenterología y Hepatología 2025; : 502346 doi: 10.1016/j.gastrohep.2025.502346
45
Federica Fascì-Spurio, Polychronis Pavlidis, Ingvar Bjarnason. A new form of chronic inflammatory bowel disease associated with chronic liver diseaseScandinavian Journal of Gastroenterology 2016; 51(6): 644 doi: 10.3109/00365521.2015.1128141
46
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020;  doi: 10.1017/9781316823026
47
Tommaso D’Angelo, Silvio Mazziotti, Alfredo Blandino, Giuseppe Cicero. MR Enterography2022; : 73 doi: 10.1007/978-3-031-11930-9_6
48
Juliana Silva, Beatriz S. Brito, Isaac Neri de N. Silva, Viviane G. Nóbrega, Maria Carolina S. M. da Silva, Hemerson Dyego de N. Gomes, Flora Maria Fortes, Andrea M. Pimentel, Jaciane Mota, Neogélia Almeida, Valdiana C. Surlo, André Lyra, Raquel Rocha, Genoile O. Santana. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease PatientsBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7604939
49
Kate D. Lynch, Roger W. Chapman, Satish Keshav, Aldo J. Montano-Loza, Andrew L. Mason, Andreas E. Kremer, Marcel Vetter, Manon de Krijger, Cyriel Y. Ponsioen, Palak Trivedi, Gideon Hirschfield, Christoph Schramm, Chung Heng Liu, Christopher L. Bowlus, Derek J. Estes, Daniel Pratt, Charlotte Hedin, Annika Bergquist, Annemarie C. de Vries, C. Janneke van der Woude, Lei Yu, David N. Assis, James Boyer, Henriette Ytting, Emina Hallibasic, Michael Trauner, Hanns-Ulrich Marschall, Luigi M. Daretti, Marco Marzioni, Kidist K. Yimam, Nicola Perin, Annarosa Floreani, Benedetta Terziroli Beretta-Piccoli, Jennifer K. Rogers, Cynthia Levy. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesClinical Gastroenterology and Hepatology 2020; 18(1): 179 doi: 10.1016/j.cgh.2019.05.013
50
David Ellinghaus. How genetic risk contributes to autoimmune liver diseaseSeminars in Immunopathology 2022; 44(4): 397 doi: 10.1007/s00281-022-00950-8
51
Blair Fennimore, Emilie H. Regner, Mark E. Gerich. Primary Sclerosing Cholangitis2017; : 29 doi: 10.1007/978-3-319-40908-5_3
52
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1): 39 doi: 10.21508/1027-4065-2021-66-1-39-46
53
Mohammad Mawardi, Abduljaleel Alalwan, Hind Fallatah, Faisal Abaalkhail, Mohammed Hasosah, Mohammad Shagrani, Mohammed Y Alghamdi, Abdullah S Alghamdi. Cholestatic liver diseaseSaudi Journal of Gastroenterology 2021; 27(Suppl 1): S1 doi: 10.4103/sjg.sjg_112_21
54
Emily Read, Michael A. Curtis, Joana F. Neves. The role of oral bacteria in inflammatory bowel diseaseNature Reviews Gastroenterology & Hepatology 2021; 18(10): 731 doi: 10.1038/s41575-021-00488-4
55
Kristel K. Leung, Maya Deeb, Sandra E. Fischer, Aliya Gulamhusein. Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future DirectionsSeminars in Liver Disease 2021; 41(03): 409 doi: 10.1055/s-0041-1730950
56
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígadoGastroenterología y Hepatología 2019; 42(5): 316 doi: 10.1016/j.gastrohep.2019.02.004
57
Maysoon Gamaleldin, Luca Stocchi. Surgical Procedures on the Cirrhotic Patient2017; : 201 doi: 10.1007/978-3-319-52396-5_15
58
Nguyen Phung Vo, Anh Ho, Linh Ho. Nanocarriers Based Colon Targeting2025; : 423 doi: 10.1016/B978-0-443-24806-1.00017-0
59
Roger M. Feakins. Non-Neoplastic Pathology of the Gastrointestinal Tract2020; : 325 doi: 10.1017/9781316823026.022
60
Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmir Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor. Limited validity of Mayo endoscopic subscore in ulcerative colitis with concomitant primary sclerosing cholangitisWorld Journal of Gastrointestinal Endoscopy 2024; 16(11): 607-616 doi: 10.4253/wjge.v16.i11.607
61
Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Elena A. Kulebina, Svetlana A. Simersina, Alexander S. Potapov, Maksim M. Lokhmatov. Primary sclerosing cholangitis in children with inflammatory bowel diseaseRussian Pediatric Journal 2022; 24(6): 395 doi: 10.46563/1560-9561-2021-24-6-395-404
62
Lauren Van Der Kraak, Philippe Gros, Nicole Beauchemin. Colitis-associated colon cancer: Is it in your genes?World Journal of Gastroenterology 2015; 21(41): 11688-11699 doi: 10.3748/wjg.v21.i41.11688
63
Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park. Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trialClinical and Molecular Hepatology 2025; 31(1): 119 doi: 10.3350/cmh.2024.0629
64
Brian H. Horwich, Douglas T. Dieterich. Phenotypes of Primary Sclerosing Cholangitis and Differential DiagnosisClinics in Liver Disease 2024; 28(1): 143 doi: 10.1016/j.cld.2023.07.006
65
Sreelakshmi Kotha, Ioannis Koumoutsos, Ben Warner, Eleni Theocharidou, Joel Mawdsley, Philip Berry. Setting up an integrated service for PSC-IBD patients: A quality improvement projectiLIVER 2024; 3(2): 100076 doi: 10.1016/j.iliver.2024.100076
66
Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in IndiaIntestinal Research 2023; 21(4): 452 doi: 10.5217/ir.2022.00087
67
Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei. Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel diseaseIntestinal Research 2022; 20(2): 224 doi: 10.5217/ir.2021.00042
68
Pilar López Serrano, Juan Turnes Vázquez. Autoimmune hepatitis, primary sclerosing cholangitis, and inflammatory bowel disease. Sequential overlap syndrome: a twist to the mosaic of autoimmunityRevista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.7512/2020
69
Kevin De Muynck, Lindsey Devisscher. Targeting osteopontin to treat primary sclerosing cholangitisCurrent Opinion in Gastroenterology 2024; 40(2): 77 doi: 10.1097/MOG.0000000000001001
70
Rebecca Little, Binita M. Kamath, Amanda Ricciuto. Pediatric Inflammatory Bowel Disease2023; : 129 doi: 10.1007/978-3-031-14744-9_11
71
Amanda Ricciuto, Bettina E. Hansen, Brian Ngo, Marina Aloi, Thomas D. Walters, Peter C. Church, Abigail Mazurek, Maryam Khan, Nicholas Carman, Iram Siddiqui, Geoffrey C. Nguyen, Binita M. Kamath, Anne M. Griffiths. Primary Sclerosing Cholangitis in Children With Inflammatory Bowel Diseases Is Associated With Milder Clinical Activity But More Frequent Subclinical Inflammation and Growth ImpairmentClinical Gastroenterology and Hepatology 2020; 18(7): 1509 doi: 10.1016/j.cgh.2019.08.048
72
Fatemeh Hadizadeh, Charlie W. Lees, Catherine Labbé, John D. Rioux, Miles Parkes, Alexandra Zhernakova, Andre Franke, Charlotte Hedin, Mauro D’Amato. Molecular Genetics of Inflammatory Bowel Disease2019; : 91 doi: 10.1007/978-3-030-28703-0_5
73
Britta Siegmund. Chronisch-entzündliche Darmerkrankungen2020; : 51 doi: 10.1007/978-3-662-59104-8_3
74
Keisuke Hata, Soichiro Ishihara, Hiroaki Nozawa, Kazushige Kawai, Tomomichi Kiyomatsu, Toshiaki Tanaka, Junko Kishikawa, Hiroyuki Anzai, Toshiaki Watanabe. Pouchitis after ileal pouch‐anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidenceDigestive Endoscopy 2017; 29(1): 26 doi: 10.1111/den.12744
75
Roger M Feakins. Morson and Dawson's Gastrointestinal Pathology2024; : 709 doi: 10.1002/9781119423195.ch35
76
Kristel K. Leung, Wenbin Li, Bettina Hansen, Aliya Gulamhusein, Lauren Lapointe-Shaw, Abdel Aziz Shaheen, Amanda Ricciuto, Eric I. Benchimol, Jennifer A. Flemming, Gideon M. Hirschfield. Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequenceJHEP Reports 2025; 7(3): 101272 doi: 10.1016/j.jhepr.2024.101272
77
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
78
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axisExperimental & Molecular Medicine 2023; 55(7): 1380 doi: 10.1038/s12276-023-01042-9
79
Johanna Eliasson, Bobby Lo, Christoph Schramm, Olivier Chazouilleres, Trine Folseraas, Ulrich Beuers, Henriette Ytting. Survey uncovering variations in the management of primary sclerosing cholangitis across EuropeJHEP Reports 2022; 4(11): 100553 doi: 10.1016/j.jhepr.2022.100553
80
Dominika Suchecka, Joanna Harasym, Jacek Wilczak, Joanna Gromadzka-Ostrowska. Hepato- and gastro- protective activity of purified oat 1–3, 1–4-β- d -glucans of different molecular weightInternational Journal of Biological Macromolecules 2016; 91: 1177 doi: 10.1016/j.ijbiomac.2016.06.062
81
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park. Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based studyIntestinal Research 2023; 21(2): 252 doi: 10.5217/ir.2022.00092
82
Amr Sayed, David N. Assis, Marina G. Silveira, Yanhong Deng, Maria Ciarleglio, Jill K.J. Gaidos, Deborah D. Proctor, Badr Al-Bawardy. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2023; 35(3): 270 doi: 10.1097/MEG.0000000000002510
83
Sheena Mago, George Y. Wu. Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A ReviewJournal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00036
84
Ruth Zhang, Gregory Y Lauwers, Won-Tak Choi. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022; 16(12): 1825 doi: 10.1093/ecco-jcc/jjac090
85
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific FeaturesGut and Liver 2018; 12(1): 17 doi: 10.5009/gnl16510
86
Way Seah Lee, Sivaramakrishnan Venkatesh Karthik, Ruey Terng Ng, Sik Yong Ong, Christina Ong, Fang K. Chiou, Shin Yee Wong, Seng Hock Quak, Marion Margaret Aw. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian childrenPediatrics & Neonatology 2019; 60(4): 396 doi: 10.1016/j.pedneo.2018.09.007
87
Josiah D. McCain, David M. Chascsa, Keith D. Lindor. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patientsExpert Opinion on Orphan Drugs 2021; 9(2): 53 doi: 10.1080/21678707.2021.1898370
88
Bence Kővári, Ágnes Báthori, Mark S. Friedman, Gregory Y. Lauwers. Histologic Diagnosis of Inflammatory Bowel DiseasesAdvances in Anatomic Pathology 2022; 29(1): 48 doi: 10.1097/PAP.0000000000000325
89
Cristian Camilo Villa-Gómez, Daniel Stiven Velilla-Aguirre, Laura Camila Lopera-Restrepo, Sergio Iván Hoyos-Duque. Colangitis esclerosante primaria. Una revisión narrativaIatreia 2020; 33(3): 251 doi: 10.17533/udea.iatreia.57
90
Shaun R. Brown, Lisa C. Coviello. Extraintestinal Manifestations Associated with Inflammatory Bowel DiseaseSurgical Clinics of North America 2015; 95(6): 1245 doi: 10.1016/j.suc.2015.08.002
91
Kate D. Lynch, Satish Keshav, Roger W. Chapman. The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing CholangitisCurrent Hepatology Reports 2019; 18(1): 115 doi: 10.1007/s11901-019-00456-2
92
Arash Motamed, Thang Tran, Mohamed H. Eloustaz. Obstetric Anesthesia and Uncommon Disorders2024; : 290 doi: 10.1017/9781009070256.019
93
Katie Ann Dunleavy, Priscila Santiago, Gerard Forde, W Scott Harmsen, Nicholas P McKenna, Nayantara Coelho-Prabhu, Sherief Shawki, Laura Raffals. Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing CholangitisInflammatory Bowel Diseases 2024; 30(11): 1935 doi: 10.1093/ibd/izad278
94
Sabrina Cardile, Tommaso Alterio, Manila Candusso, Andrea Pietrobattista, Daniela Liccardo, Maria Sole Basso, Bronislava Papadatou, Fiammetta Bracci, Daniela Knafelz, Giuliano Torre. Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectivesScandinavian Journal of Gastroenterology 2017; 52(6-7): 662 doi: 10.1080/00365521.2017.1298833
95
Meysam Olfatifar, Mohsen Rajabnia, Amir Sadeghi, Amirhassan Rabbani, Shabnam Shahrokh, Mohammad Amin Habibi, MehdiSure Pezeshgi Modarres, Mohammad Reza Zali, Hamidreza Houri, Maher Abdelraheim Titi. The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: An updated meta-analysis and modeling studyPLOS One 2025; 20(5): e0322479 doi: 10.1371/journal.pone.0322479
96
Malte Rühlemann, Timur Liwinski, Femke‐Anouska Heinsen, Corinna Bang, Roman Zenouzi, Martin Kummen, Louise Thingholm, Marie Tempel, Wolfgang Lieb, Tom Karlsen, Ansgar Lohse, Johannes Hov, Gerald Denk, Frank Lammert, Marcin Krawczyk, Christoph Schramm, Andre Franke. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitisAlimentary Pharmacology & Therapeutics 2019; 50(5): 580 doi: 10.1111/apt.15375
97
Henry Shiau, Faith D. Ihekweazu, Mansi Amin, Tatiana Fofanova, Tamir Miloh, Richard Kellermayer. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing CholangitisJournal of Pediatric Gastroenterology and Nutrition 2017; 65(4): 404 doi: 10.1097/MPG.0000000000001531
98
Souvik Sarkar, Christopher L. Bowlus. Primary Sclerosing CholangitisClinics in Liver Disease 2016; 20(1): 67 doi: 10.1016/j.cld.2015.08.005
99
Takuya Yoshino, Hiroshi Nakase, Tomohisa Takagi, Shigeki Bamba, Yusuke Okuyama, Takuji Kawamura, Teruki Oki, Hirozumi Obata, Chiharu Kawanami, Shinji Katsushima, Toshihiro Kusaka, Tomoyuki Tsujikawa, Yuji Naito, Akira Andoh, Takafumi Kogawa. Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study—CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study IBMJ Open Gastroenterology 2016; 3(1): e000122 doi: 10.1136/bmjgast-2016-000122
100
Jessica M. Ferrell. Circadian rhythms and inflammatory diseases of the liver and gutLiver Research 2023;  doi: 10.1016/j.livres.2023.08.004
101
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
102
Matteo PEVIANI, Nora CAZZAGON, Martina GAMBATO, Luisa BERTIN, Fabiana ZINGONE, Edoardo V. SAVARINO, Brigida BARBERIO. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationshipMinerva Gastroenterology 2025; 71(1) doi: 10.23736/S2724-5985.23.03605-7
103
Manon de Krijger, Manon E. Wildenberg, Wouter J. de Jonge, Cyriel Y. Ponsioen. Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitisJournal of Hepatology 2019; 71(3): 603 doi: 10.1016/j.jhep.2019.05.006
104
Istvan Fedor, Eva Zold, Zsolt Barta. Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel DiseasesLife 2023; 13(3): 652 doi: 10.3390/life13030652
105
Hiep Nguyen Canh, Kenichi Harada. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinomaMedical Molecular Morphology 2016; 49(4): 189 doi: 10.1007/s00795-016-0143-6
106
Shailja C. Shah, Joren R. ten Hove, Daniel Castaneda, Carolina Palmela, Erik Mooiweer, Jean-Frédéric Colombel, Noam Harpaz, Thomas A. Ullman, Ad A. van Bodegraven, Jeroen M. Jansen, Nofel Mahmmod, Andrea E. van der Meulen-de Jong, Cyriel Y. Ponsioen, Christine J. van der Woude, Bas Oldenburg, Steven H. Itzkowitz, Joana Torres. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology 2018; 16(7): 1106 doi: 10.1016/j.cgh.2018.01.023
107
Nan Wu, Fanyin Meng, Pietro Invernizzi, Francesca Bernuzzi, Julie Venter, Holly Standeford, Paolo Onori, Marco Marzioni, Domenico Alvaro, Antonio Franchitto, Eugenio Gaudio, Shannon Glaser, Gianfranco Alpini. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor‐β1 biliary secretion in miceHepatology 2016; 64(3): 865 doi: 10.1002/hep.28622
108
Morten L Halling, Jens Kjeldsen, Torben Knudsen, Jan Nielsen, Lars Koch Hansen. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseasesWorld Journal of Gastroenterology 2017; 23(33): 6137-6146 doi: 10.3748/wjg.v23.i33.6137
109
Alexander J. Kovalic, Herbert L. Bonkovsky. Diagnosis and Management of Autoimmune Hepatitis2020; : 9 doi: 10.1007/978-3-030-33628-8_2
110
Brigida Barberio, Davide Massimi, Nora Cazzagon, Fabiana Zingone, Alexander C. Ford, Edoardo V. Savarino. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysisGastroenterology 2021; 161(6): 1865 doi: 10.1053/j.gastro.2021.08.032
111
Girak Kim, Zuojia Chen, Jian Li, Jialie Luo, Felipe Castro-Martinez, Jan Wisniewski, Kairong Cui, Yan Wang, Jialei Sun, Xiaobai Ren, Susan E. Crawford, S. Patricia Becerra, Jimin Zhu, Taotao Liu, Sui Wang, Keji Zhao, Chuan Wu. Gut-liver axis calibrates intestinal stem cell fitnessCell 2024; 187(4): 914 doi: 10.1016/j.cell.2024.01.001
112
Federica Del Chierico, Sabrina Cardile, Valerio Baldelli, Tommaso Alterio, Sofia Reddel, Matteo Bramuzzo, Daniela Knafelz, Sara Lega, Fiammetta Bracci, Giuliano Torre, Giuseppe Maggiore, Lorenza Putignani. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative ColitisInflammatory Bowel Diseases 2024; 30(4): 529 doi: 10.1093/ibd/izad203
113
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary MalignanciesInternational Journal of Molecular Sciences 2021; 22(13): 6975 doi: 10.3390/ijms22136975
114
Sabina Wiecek, Alicja Wojtyniak, Barbara Pindur, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Urszula Grzybowska-Chlebowczyk. Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population—Single Center StudyMedicina 2021; 57(7): 663 doi: 10.3390/medicina57070663
115
Felix Solberg, Bodil Ohlsson. Microscopic colitis and its associations with complications observed in classic inflammatory bowel disease: a systematic reviewScandinavian Journal of Gastroenterology 2020; 55(3): 312 doi: 10.1080/00365521.2020.1739325
116
Sun-Gou Ji, Brian D Juran, Sören Mucha, Trine Folseraas, Luke Jostins, Espen Melum, Natsuhiko Kumasaka, Elizabeth J Atkinson, Erik M Schlicht, Jimmy Z Liu, Tejas Shah, Javier Gutierrez-Achury, Kirsten M Boberg, Annika Bergquist, Severine Vermeire, Bertus Eksteen, Peter R Durie, Martti Farkkila, Tobias Müller, Christoph Schramm, Martina Sterneck, Tobias J Weismüller, Daniel N Gotthardt, David Ellinghaus, Felix Braun, Andreas Teufel, Mattias Laudes, Wolfgang Lieb, Gunnar Jacobs, Ulrich Beuers, Rinse K Weersma, Cisca Wijmenga, Hanns-Ulrich Marschall, Piotr Milkiewicz, Albert Pares, Kimmo Kontula, Olivier Chazouillères, Pietro Invernizzi, Elizabeth Goode, Kelly Spiess, Carmel Moore, Jennifer Sambrook, Willem H Ouwehand, David J Roberts, John Danesh, Annarosa Floreani, Aliya F Gulamhusein, John E Eaton, Stefan Schreiber, Catalina Coltescu, Christopher L Bowlus, Velimir A Luketic, Joseph A Odin, Kapil B Chopra, Kris V Kowdley, Naga Chalasani, Michael P Manns, Brijesh Srivastava, George Mells, Richard N Sandford, Graeme Alexander, Daniel J Gaffney, Roger W Chapman, Gideon M Hirschfield, Mariza de Andrade, Simon M Rushbrook, Andre Franke, Tom H Karlsen, Konstantinos N Lazaridis, Carl A Anderson. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel diseaseNature Genetics 2017; 49(2): 269 doi: 10.1038/ng.3745
117
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A reviewWorld Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
118
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018)Terapevticheskii arkhiv 2019; 91(2): 9 doi: 10.26442/00403660.2019.02.000075
119
Sabina Wiecek. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy2022;  doi: 10.5772/intechopen.102080
120
Rodrigo V Motta, Vipin Gupta, Karen Hartery, Paul Bassett, Simon J Leedham, Roger W Chapman, Simon PL Travis, Emma L Culver, James E. East. Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBDEndoscopy International Open 2024; 12(11): E1285 doi: 10.1055/a-2437-8102
121
Mindy C Ward, Blake Studer, Ian Nora, Nathan Seepaulsing, Charles Loewe. Primary Sclerosing Cholangitis in Crohn’s Disease: An Atypical ComplicationCureus 2021;  doi: 10.7759/cureus.14964
122
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelationGastroenterología y Hepatología (English Edition) 2019; 42(5): 316 doi: 10.1016/j.gastre.2019.02.030
123
Taku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, Haruhiko Ogata, Akira Andoh, Toshimitsu Araki, Ryota Hokari, Hideki Iijima, Hiroki Ikeuchi, Yoh Ishiguro, Shingo Kato, Reiko Kunisaki, Takayuki Matsumoto, Satoshi Motoya, Masakazu Nagahori, Shiro Nakamura, Hiroshi Nakase, Tomoyuki Tsujikawa, Makoto Sasaki, Kaoru Yokoyama, Naoki Yoshimura, Kenji Watanabe, Miiko Katafuchi, Mamoru Watanabe, Toshifumi Hibi. Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countriesIntestinal Research 2018; 16(2): 168 doi: 10.5217/ir.2018.16.2.168
124
Sabina Wiecek. Hepatitis A and Other Associated Hepatobiliary Diseases2020;  doi: 10.5772/intechopen.90714
125
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing CholangitisClinics in Liver Disease 2024; 28(1): 129 doi: 10.1016/j.cld.2023.07.005
126
Lídia Roque Ramos, Christopher J. DiMaio, David B. Sachar, Ashish Atreja, Jean-Frédéric Colombel, Joana Torres. Autoimmune pancreatitis and inflammatory bowel disease: Case series and review of the literatureDigestive and Liver Disease 2016; 48(8): 893 doi: 10.1016/j.dld.2016.05.008
127
Friederike Stumme, Niklas Steffens, Babett Steglich, Franziska Mathies, Mikolaj Nawrocki, Morsal Sabihi, Shiwa Soukou-Wargalla, Emilia Göke, Jan Kempski, Thorben Fründt, Sören Weidemann, Christoph Schramm, Nicola Gagliani, Samuel Huber, Tanja Bedke. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitisFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1307297
128
Trevor J Laborda, M Kyle Jensen, Marianne Kavan, Mark Deneau. Treatment of primary sclerosing cholangitis in childrenWorld Journal of Hepatology 2019; 11(1): 19-36 doi: 10.4254/wjh.v11.i1.19
129
Andrew J. Muir. What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?Clinical Gastroenterology and Hepatology 2020; 18(10): 2173 doi: 10.1016/j.cgh.2020.03.053
130
Rosario Fornaro, Michela Caratto, Elisa Caratto, Giuseppe Caristo, Francesco Fornaro, Davide Giovinazzo, Camilla Sticchi, Marco Casaccia, Enzo Andorno. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance ProgramClinical Colorectal Cancer 2016; 15(3): 204 doi: 10.1016/j.clcc.2016.02.002
131
Fen Ming Zhang, Cheng Fu Xu, Guo Dong Shan, Hong Tan Chen, Guo Qiang Xu. Is gallstone disease associated with inflammatory bowel diseases? A meta‐analysisJournal of Digestive Diseases 2015; 16(11): 634 doi: 10.1111/1751-2980.12286
132
Haim Leibovitzh, Shadi Nayeri, Krzysztof Borowski, Cristian Hernandez-Rocha, Sun-Ho Lee, Williams Turpin, Joanne M Stempak, Iqbaljit Sandhu, Raquel Milgrom, Michelle I Smith, Kenneth Croitoru, Gideon M Hirschfield, Aliya Gulamhusein, Mark S Silverberg. Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid ProfileJournal of Crohn's and Colitis 2024; 18(12): 1957 doi: 10.1093/ecco-jcc/jjae096
133
Claire Kelly, Yoh Zen, Michael A. Heneghan. Post-Transplant Immunosuppression in Autoimmune Liver DiseaseJournal of Clinical and Experimental Hepatology 2023; 13(2): 350 doi: 10.1016/j.jceh.2022.07.002
134
MT Ko, A Hammodi. How to approach jaundice in the MRCP PACES examBritish Journal of Hospital Medicine 2023; 84(2): 1 doi: 10.12968/hmed.2022.0438
135
Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matías A. Ávila, Yulia A. Nevzorova, Francisco Javier Cubero. Fibrotic Events in the Progression of Cholestatic Liver DiseaseCells 2021; 10(5): 1107 doi: 10.3390/cells10051107
136
Jessica Colin Escobar, Maria Navarez Pereyra, Mohammad Ali Abbass. Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseSurgical Clinics of North America 2025; 105(2): 375 doi: 10.1016/j.suc.2024.11.001
137
Serena Bertoni, Ariella Machness, Mattia Tiboni, Raquel Bártolo, Hélder A. Santos. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targetingBiopolymers 2020; 111(1) doi: 10.1002/bip.23336
138
Craig Lammert, Veronica M. Loy, Kiyoko Oshima, Samer Gawrieh. Management of Difficult Cases of Autoimmune HepatitisCurrent Gastroenterology Reports 2016; 18(2) doi: 10.1007/s11894-015-0484-7
139
John M. Vierling. Primary Sclerosing Cholangitis2017; : 111 doi: 10.1007/978-3-319-40908-5_9
140
Nahla Azzam, Yazed AlRuthia, Othman Alharbi, Abdulrahman Aljebreen, Majid Almadi, Edward V. Loftus. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel diseaseHepatology International 2020; 14(6): 1114 doi: 10.1007/s12072-020-10110-5
141
Wassel Sannaa, Mazen Almasry, Mustafa Peedikayil, Alyssa A. Grimshaw, Mashary Attamimi, Abdulelah AlMutairdi, Badr Al-Bawardy. Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysisTherapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848241312766
142
Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly Monroe, Billy D Nix, Rodney D Newberry, William A Faubion. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel diseaseBMJ Open Gastroenterology 2023; 10(1): e001141 doi: 10.1136/bmjgast-2023-001141
143
Chuan Liu, Rong Yu, Jixiang Zhang, Shuchun Wei, Fumin Xue, Yingyun Guo, Pengzhan He, Lining Shang, Weiguo Dong. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.972079
144
Luca Maroni, Elisabetta Ninfole, Claudio Pinto, Antonio Benedetti, Marco Marzioni. Gut–Liver Axis and Inflammasome Activation in Cholangiocyte PathophysiologyCells 2020; 9(3): 736 doi: 10.3390/cells9030736
145
Lukáš Bajer, Pavel Wohl, Pavel Drastich. PSC-IBD: specific phenotype of inflammatory bowel disease associated with primary sclerosing cholangitisVnitřní lékařství 2018; 64(6): 659 doi: 10.36290/vnl.2018.090
146
Christopher L. Bowlus. Liver Immunology2020; : 395 doi: 10.1007/978-3-030-51709-0_25
147
João Sabino, Joren tenHove, Joana Torres. Biomarkers in Inflammatory Bowel Diseases2019; : 191 doi: 10.1007/978-3-030-11446-6_16
148
Lina Lindström, Kristin K. Jørgensen, Kirsten M. Boberg, Maria Castedal, Allan Rasmussen, Andreas Arendtsen Rostved, Helena Isoniemi, Matteo Bottai, Annika Bergquist. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre StudyScandinavian Journal of Gastroenterology 2018; 53(3): 297 doi: 10.1080/00365521.2017.1421705
149
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus ProcessGastroenterology 2021; 161(6): 1764 doi: 10.1053/j.gastro.2021.07.046
150
Patrick F. van Rheenen, Kaija‐Leena Kolho, Richard K. Russell, Marina Aloi, Annamaria Deganello, Séamus Hussey, Norman Junge, Jan De Laffolie, Mark R. Deneau, Emer Fitzpatrick, Anne M. Griffiths, Iva Hojsak, Emanuele Nicastro, Andreia Nita, Mikko Pakarinen, Amanda Ricciuto, Lissy de Ridder, Aurelio Sonzogni, Andrea Tenca, Marianne Samyn, Giuseppe Indolfi. Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology Committee and the IBD Porto groupJournal of Pediatric Gastroenterology and Nutrition 2025; 80(2): 374 doi: 10.1002/jpn3.12378
151
Kim N. van Munster, Annika Bergquist, Cyriel Y. Ponsioen. Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?Journal of Hepatology 2024; 80(1): 155 doi: 10.1016/j.jhep.2023.09.031
152
Dibya L. Praharaj, Anil C. Anand. Hepatology2025; : 1003 doi: 10.1016/B978-0-443-26711-6.00036-6
153
Jessica K Dyson, Ulrich Beuers, David E J Jones, Ansgar W Lohse, Mark Hudson. Primary sclerosing cholangitisThe Lancet 2018; 391(10139): 2547 doi: 10.1016/S0140-6736(18)30300-3
154
Atsushi Tanaka, Joachim C. Mertens. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?Inflammatory Intestinal Diseases 2016; 1(1): 9 doi: 10.1159/000445259
155
Bence Kővári, Rish K. Pai. Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and PitfallsAdvances in Anatomic Pathology 2022; 29(1): 2 doi: 10.1097/PAP.0000000000000311
156
Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip. What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current LiteratureMetabolites 2023; 13(3): 378 doi: 10.3390/metabo13030378
157
Xiaoyong Xue, Jianzhi Wu, Mingning Ding, Feng Gao, Fei Zhou, Bing Xu, Mingjun Lu, Jun Li, Xiaojiaoyang Li. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasisChinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00524-0
158
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive reviewJournal of Hepatology 2017; 67(6): 1298 doi: 10.1016/j.jhep.2017.07.022
159
Amanda Ricciuto, Binita M. Kamath, Anne M. Griffiths. The IBD and PSC Phenotypes of PSC-IBDCurrent Gastroenterology Reports 2018; 20(4) doi: 10.1007/s11894-018-0620-2
160
Bo Shen. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease2020; : 35 doi: 10.1016/B978-0-12-814811-2.00004-9
161
Rinse K. Weersma, Keith D. Lindor. Shifting Paradigms: What Is the True Prevalence and Clinical Course of Primary Sclerosing Cholangitis?Gastroenterology 2016; 151(4): 590 doi: 10.1053/j.gastro.2016.08.046
162
Kai Markus Schneider, Lena Susanna Candels, Johannes R. Hov, Maiju Myllys, Reham Hassan, Carolin Victoria Schneider, Annika Wahlström, Antje Mohs, Sebastian Zühlke, Lijun Liao, Carsten Elfers, Konrad Kilic, Marcus Henricsson, Antonio Molinaro, Maximilian Hatting, Ayham Zaza, Dirk Drasdo, Mick Frissen, A. Sloan Devlin, Eric J. C. Gálvez, Till Strowig, Tom H. Karlsen, Jan G. Hengstler, Hanns-Ulrich Marschall, Ahmed Ghallab, Christian Trautwein. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signallingNature Metabolism 2021; 3(9): 1228 doi: 10.1038/s42255-021-00452-1
163
Ruth Zhang, Dongliang Wang, Gregory Y. Lauwers, Won-Tak Choi. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative ColitisAmerican Journal of Surgical Pathology 2024; 48(9): 1154 doi: 10.1097/PAS.0000000000002255
164
Noa Krugliak Cleveland, David T. Rubin, John Hart, Christopher R. Weber, Katherine Meckel, Anthony L. Tran, Arthur S. Aelvoet, Isabella Pan, Alex Gonsalves, John Nick Gaetano, Kelli M. Williams, Kristen Wroblewski, Bana Jabri, Joel Pekow. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal ColonClinical Gastroenterology and Hepatology 2018; 16(1): 68 doi: 10.1016/j.cgh.2017.07.023
165
Igor G. Bakulin, Svetlana A. Burlakova, Ekaterina V. Skazyvaeva, Maria I. Skalinskaya. Registry of patients with autoimmune liver diseases in St. Petersburg: clinical and epidemiological dataHERALD of North-Western State Medical University named after I.I. Mechnikov 2024; 16(2): 61 doi: 10.17816/mechnikov627505
166
S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)Zeitschrift für Gastroenterologie 2025; 63(06): 604 doi: 10.1055/a-2558-5204